Sio Gene Therapies

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SIOX and other ETFs, options, and stocks.

About SIOX

Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focuses on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis, such as Tay-Sachs disease and Sandhoff disease. 

CEO
David W. Nassif
CEODavid W. Nassif
Employees
12
Employees12
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2014
Founded2014
Employees
12
Employees12

SIOX Key Statistics

Market cap
21.02M
Market cap21.02M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
352.62K
Average volume352.62K
High today
$0.31
High today$0.31
Low today
$0.2737
Low today$0.2737
Open price
$0.31
Open price$0.31
Volume
597.74K
Volume597.74K
52 Week high
$2.66
52 Week high$2.66
52 Week low
$0.2303
52 Week low$0.2303

SIOX Earnings

-$0.35
-$0.23
-$0.12
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Estimated
per share
Estimated per share
Actual
Expected Nov 11, Pre-Market
ActualExpected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.